期刊文献+

小剂量倍他乐克治疗慢性心力衰竭疗效观察 被引量:5

Clinical observation of small dose Betaloc in the treatment of chronic heart failure
下载PDF
导出
摘要 目的:观察小剂量倍他乐克治疗慢性心力衰竭的疗效。方法:将慢性心力衰竭96例随机分为具有可比性的治疗组和对照组,在所有病例均给予强心、利尿和扩血管等常规治疗,治疗组同时加用倍他乐克,自12.5mg/d开始,3~5d后增至25mg/d,以后逐渐增加至50~75mg/d。治疗前后观察两组患者的心率、左室射血分数(LVEF)、左室舒张末内径(LVEDD)及心功能情况。结果:治疗组显效15例,占30.6%;有效22例,占44.9%;无效12例,占24.5%;总有效率为75.5%。对照组显效9例,占20.5%;有效12例,占27.3%;无效23例,占52.3%;总有效率为47.7%。治疗后两组之间的总有效率、心率和心功能差异均有统计学意义(P<0.05)。结论:在接受心力衰竭常规治疗基础上加服小剂量倍他乐克对改善心力衰竭症状具有良好效果。 Objective:To observe the curative effect of small dose Betaloc in the treatment of chronic heart failure. Methods:96 cases of chronic heart failure patients were divided into treatment group andcontrol group. Conventional cardiac,diuresis and vasodilatation treatment were given to both groups,while extra Betaloc treatment was given to the treatment group,starting with giving Betaloc 12.5 mg/d,3~5 days later,increase to 25 mg/d,and progressive increase to 50~75 mg/d; the heart rate,LVEF,LVEDD and heart function of the patients in both groups before and after treatment were observed. Results:The difference in total effective rate,heart rate and heart function between the two groups was of statistical significance. Conclusion:The routine treatment plus small dose Betaloc has good effect in improving the symptoms of heart failure.
作者 王振华
出处 《中国医药导报》 CAS 2008年第23期66-67,共2页 China Medical Herald
关键词 心力衰竭 倍他乐克 Heart failure;Betaloc
  • 相关文献

参考文献2

二级参考文献11

  • 1Packer M, Bristow WR. Effect of carvedilol on morbidity and mortality inchronic failure[J]. N Engl J Med,1996,334(6) :1349. 被引量:1
  • 2Maisel AS, Krishnaswamy P, Nowak R. et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure[J]. N Engl J Med,2002,347(14) :1126. 被引量:1
  • 3Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death[J]. N Engl J Med,2004 ,350( 7 ) :665 -663. 被引量:1
  • 4Maeda K,Takayoshi T,Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patient with symptomatic left ventricular dysfunction[J].Am Heart J,1998,135:825 -832. 被引量:1
  • 5Sudoh T, Maekawa K, Kojima M ,et al. Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide [J]. Biochem Biophys Res Commun, 1989,159:1427 - 1434. 被引量:1
  • 6Luchner A, Stevens TL, Borgeson DD, et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure[J]. Am J Physiol, 1998,274: H1684 - H1689. 被引量:1
  • 7Harrison A, Morrison LK, Krishnaswamy P, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea[J]. Ann Emerg Med, 2002,39:131 -138. 被引量:1
  • 8Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure[J]. Circulation, 1994,90:195 -203. 被引量:1
  • 9Groenning BA, Nillsson JC, Sondergaard L, et al. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentratrions [J]. European Journal of heart failure ,2001,3:699 - 708. 被引量:1
  • 10Mottram PM, Leano R, Marwick TH. Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function [J]. Am J Cardiol,2003,92(12): 1434 - 1438. 被引量:1

共引文献151

同被引文献31

  • 1申向华.倍他乐克与雅施达联用治疗慢性心力衰竭临床观察[J].中国医药导报,2007,4(01X):76-77. 被引量:11
  • 2中华人民共和国卫生部主编.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:127-128. 被引量:469
  • 3蔡楚华,王芸.倍他乐克治疗慢性心衰68例疗效分析[J].中国药物经济学,2012,08(02):269-270. 被引量:2
  • 4Hasegwa K,Iwaikanai E,Sasayama S.Ncurohormonal regulation of myocardial cell apoptosis during the dcgulation of heart failure[J].Cell physio 1,2001,18(6): 11-18. 被引量:1
  • 5无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3680
  • 6Yooh CH,Youn TJ,Ahn S,et al.Low serum total cholesterol level is a surrogate marker,but not a risk factor,for poor outcome in patients hospitalized with acute heart failure,a report from the Korean Heart Failure Registry[J].J Card Fail,2012,18(3):194-201. 被引量:1
  • 7Lossnitzer N,Herzog W,Stork S,et al.Incidengce rates and predictors of major and minor depression in patients with heart failure[J].Int J Cardiol,2013,167(2):502-507. 被引量:1
  • 8Gupta DK,Shah AM,Castagno D,et al.Heart failure with preserved ejection fraction in African Americans.The ARIC(Atherosclersis Risk in Communities)study[J].JACC Heart Fail,2013,1(2):156-163. 被引量:1
  • 9云娟娟.1274例慢性心力衰竭患者病因及预后的调查分析[J].昆明医科大学,2013,11(27):165-166. 被引量:1
  • 10Vittorio TJ,Zolty R,Kasper ME,et al.Differential effects of carvedilol and metoprolol succinate on plasma norepinephrine release and peak exercise heart rate in subjects with chronic heart failure[J].J Cardiovasc Pharmacol Ther,2008,13(1):51-57. 被引量:1

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部